BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31068562)

  • 21. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma.
    Appio L; Landoni C; La Targia M; Bertolli V; Chiarucci M; Crovetti G; Vassenna E; Serio G; Bregni M
    Chemotherapy; 2017; 62(3):187-191. PubMed ID: 28334700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
    Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL
    Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orbital MALT Lymphoma after Autologous Stem Cell Transplantation for Follicular Lymphoma as Relapse of Diffuse Large B-Cell Lymphoma.
    Matsuo T; Tanaka T; Fujii N
    J Clin Exp Hematop; 2017; 56(3):170-175. PubMed ID: 28331132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rituximab plus Autologous Hemotopoietic Stem Cell Transplantation for The Treatment of CD5 Positive Diffuse Large B Cell Lymphoma with Autoimmune Hemolytic Anemia].
    Huang YQ; Zheng RJ; Wu RJ; Ma XD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):722-6. PubMed ID: 27342498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
    Janikova A; Chloupkova R; Campr V; Klener P; Hamouzova J; Belada D; Prochazka V; Pytlik R; Pirnos J; Duras J; Mocikova H; Bortlicek Z; Kopalova N; Mayer J; Trneny M
    Ann Hematol; 2019 Aug; 98(8):1961-1972. PubMed ID: 31065733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.
    Evens AM; Winter JN; Hou N; Nelson BP; Rademaker A; Patton D; Singhal S; Frankfurt O; Tallman MS; Rosen ST; Mehta J; Gordon LI
    Br J Haematol; 2008 Feb; 140(4):385-93. PubMed ID: 18162124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
    Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL
    Cancer; 2008 Nov; 113(9):2496-503. PubMed ID: 18833583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction with MEDA regimen and consolidation with Auto-HSCT for stage IV NKTCL patients: A prospective multicenter study.
    Liu C; Ding H; Zhu Q; Liu P; Zhu Y; Wang L; Ma Y; Zhang W; Tian S; Zhang X; Jin L; Liu L; Li Z; Hao S; Tao R
    Int J Cancer; 2022 Sep; 151(5):752-763. PubMed ID: 35489026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
    Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E
    Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous peripheral blood stem cell transplantation.
    Waldmann V; Goldschmidt H; Jäckel A; Deichmann M; Hegenbart U; Hartschuh W; Ho A; Näher H
    Br J Dermatol; 2000 Oct; 143(4):837-9. PubMed ID: 11069467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET-CT confirmed complete remission and MRD negativity in mantle cell lymphoma patients treated with R-hyper-CVAD results in excellent outcome in the absence of autologous stem cell transplantation: a single-centre case for a transplant-free approach.
    Htet S; Lane S; Kipp D; Rose H; Campbell P
    Intern Med J; 2016 Sep; 46(9):1113-4. PubMed ID: 27633474
    [No Abstract]   [Full Text] [Related]  

  • 34. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
    Kanaji N; Ishibashi K; Uno H; Hino N
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Early relapse after autologous peripheral blood stem cell transplantation in an elderly patient with enteropathy-associated T-cell lymphoma].
    Sumii Y; Yamamoto K; Omura Y; Oda W; Kondo E; Oyama T; Kamoi C; Shiraishi Y; Yamamoto Y; Niiya D; Shiote Y; Imajo K
    Rinsho Ketsueki; 2018; 59(7):889-894. PubMed ID: 30078799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience of bendamustine for adult Langerhans cell sarcoma].
    Miyazawa Y; Tahara K; Yuzuriha A; Mihara M; Toyama K; Yokohama A; Handa H; Jinbo T
    Rinsho Ketsueki; 2014 May; 55(5):563-9. PubMed ID: 24881923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
    Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autologous peripheral blood stem cell transplantation for CHOP-resistant mediastinal diffuse large B-cell lymphoma].
    Kawabata Y; Hirokawa M; Horiuchi T; Hatakeyama T; Kobayashi Y; Saito K; Kume M; Nimura T; Nishinari T; Miura AB
    Rinsho Ketsueki; 1997 Aug; 38(8):674-81. PubMed ID: 9311274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
    Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
    Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature.
    Alduaij A; Butera JN; Treaba D; Castillo J
    Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):480-3. PubMed ID: 21156467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.